18217 Investors following Aurobindo Pharm. Share this News with them.
0
Like this story, share it with millions of investors on M3
Aurobindo Pharma gets approval for Perindopril Erbumine tab
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approvals from the US Food & Drug Administration for Perindopril Erbumine Tablets 2mg, 4mg, 8mg and Escitalopram Oxalate Oral solution 5mg (base) / 5ml.
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approvals from the US Food & Drug Administration (USFDA) for Perindopril Erbumine Tablets 2mg, 4mg, 8mg and Escitalopram Oxalate Oral solution 5mg (base) / 5ml.
Perindopril Erbumine Tablets are the generic equivalent of Solvay Pharmaceuticals' Aceon® Tablets, falls under the CVS segment and indicated for the treatment of patients with essential hypertension.
Escitalopram Oxalate Oral solution are the generic equivalent of Forest Laboratories' Lexapro® Oral Solution, falls under the CNS segment and indicated for the treatment of major depressive disorder.
Aurobindo now has 85 approved ANDAs from the USFDA (61 Final approvals, 24 Tentative approvals)
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Uninor | Namma Metro | LIC Housing Finance | Tata Steel | Reliance Industries | BSE Sensex | Aurobindo Pharma | Montek Singh Ahluwalia | Vodafone Essar | Iran 
